UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Selecting patients for extended adjuvant endocrine therapy

Breast (Edinburgh), 2017-03, Vol.32, p.S20-S20

Dowsett, M

2017

Volltextzugriff (PDF)

SP003 Pathology challenges for biology-driven trials: The Ki67 experience

European journal of cancer (1990), 2013-11, Vol.49, p.S1-S2

Dowsett, M

2013

Volltextzugriff (PDF)

PG 8.02 Neoadjuvant endocrine therapy: patient selection, treatment duration and surrogate endpoints

Breast (Edinburgh), 2015-03, Vol.24, p.S14-S14

Dowsett, M

2015

Volltextzugriff (PDF)

Identifying clinically relevant prognostic subgroups of postmenopausal women with node-positive hormone receptor-positive early-stage breast cancer treated with endocrine therapy: a combined analysis of ABCSG-8 and ATAC using the PAM50 risk of recurrence score and intrinsic subtype

Annals of oncology, 2015-08, Vol.26 (8), p.1685-1691

2015

Volltextzugriff (PDF)

Abstract PL1: Genomic Profiling in Early Stage ER Positive Breast Cancers/Precision Medicine

Cancer research (Chicago, Ill.), 2022-02, Vol.82 (4_Supplement), p.PL1-PL1

Dowsett, M

2022

Volltextzugriff (PDF)

Caution: Vaginal estradiol appears to be contraindicated in postmenopausal women on adjuvant aromatase inhibitors

Annals of oncology, 2006-04, Vol.17 (4), p.584-587

2006

Volltextzugriff (PDF)

Benefit from adjuvant tamoxifen therapy in primary breast cancer patients according oestrogen receptor, progesterone receptor, EGF receptor and HER2 status

Annals of oncology, 2006-05, Vol.17 (5), p.818-826

2006

Volltextzugriff (PDF)

Discordance between core needle biopsy (CNB) and excisional biopsy (EB) for estrogen receptor (ER), progesterone receptor (PgR) and HER2 status in early breast cancer (EBC)

Annals of oncology, 2009-12, Vol.20 (12), p.1948-1952

2009

Volltextzugriff (PDF)

Clinical utility of the IHC4+C score in oestrogen receptor-positive early breast cancer: a prospective decision impact study

British journal of cancer, 2015-07, Vol.113 (3), p.390-395

2015

Volltextzugriff (PDF)

The AURORA initiative for metastatic breast cancer

British journal of cancer, 2014-11, Vol.111 (10), p.1881-1887

2014

Volltextzugriff (PDF)

Abstract ES5-2: Clinical and molecular profiles to identify who is at risk?

Cancer research (Chicago, Ill.), 2019-02, Vol.79 (4_Supplement), p.ES5-2-ES5-2

Dowsett, M

2019

Volltextzugriff (PDF)

Healing of a ruptured anterior cruciate ligament and patient-reported outcomes following non-surgical management with a novel bracing protocol

Journal of science and medicine in sport, 2022-11, Vol.25, p.S27

2022

Volltextzugriff (PDF)

Changes in breast cancer biomarkers in the IGF1R/PI3K pathway in recurrent breast cancer after tamoxifen treatment

Endocrine-related cancer, 2011-10, Vol.18 (5), p.565-577

2011

Volltextzugriff (PDF)

Prognostic value of endopredict for invasive lobular carcinomas in the combined ABCSG-6/8 and TransATAC trials

Annals of oncology, 2019-05, Vol.30, p.iii1-iii1

2019

Volltextzugriff (PDF)

Biomarker changes associated with the development of resistance to aromatase inhibitors (AIs) in estrogen receptor-positive breast cancer

Annals of oncology, 2014-03, Vol.25 (3), p.605-610

2014

Volltextzugriff (PDF)

Relationship between IHC4 score and response to neo-adjuvant chemotherapy in estrogen receptor-positive breast cancer

Breast cancer research and treatment, 2017-07, Vol.164 (2), p.395-400

2017

Volltextzugriff (PDF)

S13 Cytotoxic drugs: The endocrine part of the story

Breast (Edinburgh), 2011, Vol.20, p.S5-S5

Dowsett, M

2011

Volltextzugriff (PDF)

Hormonal impact of the 17α-hydroxylase/C17,20-lyase inhibitor abiraterone acetate (CB7630) in patients with prostate cancer

British journal of cancer, 2004-05, Vol.90 (12), p.2317-2325

2004

Volltextzugriff (PDF)

Evaluation of FLT-PET-CT as an imaging biomarker of proliferation in primary breast cancer

British journal of cancer, 2014-06, Vol.110 (12), p.2847-2854

2014

Volltextzugriff (PDF)

Combined effects of endogenous sex hormone levels and mammographic density on postmenopausal breast cancer risk: results from the Breakthrough Generations Study

British journal of cancer, 2014-04, Vol.110 (7), p.1898-1907

2014

Volltextzugriff (PDF)

Combination therapy with aromatase inhibitors: the next era of breast cancer treatment?

British journal of cancer, 2006-09, Vol.95 (6), p.661-666

2006

Volltextzugriff (PDF)

Polymorphisms Associated With Circulating Sex Hormone Levels in Postmenopausal Women

JNCI : Journal of the National Cancer Institute, 2004-06, Vol.96 (12), p.936-945

2004

Volltextzugriff (PDF)

HER2 testing in the UK: further update to recommendations

Journal of clinical pathology, 2008-07, Vol.61 (7), p.818-824

2008

Volltextzugriff (PDF)

Enhanced expression of the PDGFR/Abl signaling pathway in aromatase inhibitor-resistant breast cancer

Annals of oncology, 2013-01, Vol.24 (1), p.126-133

2013

Volltextzugriff (PDF)

Interim analysis of the incidence of breast cancer in the Royal Marsden Hospital tamoxifen randomised chemoprevention trial

The Lancet (British edition), 1998-07, Vol.352 (9122), p.98-101

1998

Volltextzugriff (PDF)

1 – 25 von 1.234

Suche als RSS-Feed

Aktive Filter

SpracheJapanisch

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(1.128)
Mit Volltextzugriff
(1.083)

Publikationsform

4 weitere anzeigen...

Weniger anzeigen...

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(2)
... seit 90 Tagen
(4)

Menü

Weitere Dienste

Einstellungen

Selecting patients for extended adjuvant endocrine therapy

SP003 Pathology challenges for biology-driven trials: The Ki67 experience

PG 8.02 Neoadjuvant endocrine therapy: patient selection, treatment duration and surrogate endpoints

Identifying clinically relevant prognostic subgroups of postmenopausal women with node-positive hormone receptor-positive early-stage breast cancer treated with endocrine therapy: a combined analysis of ABCSG-8 and ATAC using the PAM50 risk of recurrence score and intrinsic subtype

Abstract PL1: Genomic Profiling in Early Stage ER Positive Breast Cancers/Precision Medicine

Caution: Vaginal estradiol appears to be contraindicated in postmenopausal women on adjuvant aromatase inhibitors

Benefit from adjuvant tamoxifen therapy in primary breast cancer patients according oestrogen receptor, progesterone receptor, EGF receptor and HER2 status

Discordance between core needle biopsy (CNB) and excisional biopsy (EB) for estrogen receptor (ER), progesterone receptor (PgR) and HER2 status in early breast cancer (EBC)

Clinical utility of the IHC4+C score in oestrogen receptor-positive early breast cancer: a prospective decision impact study

The AURORA initiative for metastatic breast cancer

Abstract ES5-2: Clinical and molecular profiles to identify who is at risk?

Healing of a ruptured anterior cruciate ligament and patient-reported outcomes following non-surgical management with a novel bracing protocol

Changes in breast cancer biomarkers in the IGF1R/PI3K pathway in recurrent breast cancer after tamoxifen treatment

Prognostic value of endopredict for invasive lobular carcinomas in the combined ABCSG-6/8 and TransATAC trials

Biomarker changes associated with the development of resistance to aromatase inhibitors (AIs) in estrogen receptor-positive breast cancer

Relationship between IHC4 score and response to neo-adjuvant chemotherapy in estrogen receptor-positive breast cancer

S13 Cytotoxic drugs: The endocrine part of the story

Hormonal impact of the 17α-hydroxylase/C17,20-lyase inhibitor abiraterone acetate (CB7630) in patients with prostate cancer

Evaluation of FLT-PET-CT as an imaging biomarker of proliferation in primary breast cancer

Combined effects of endogenous sex hormone levels and mammographic density on postmenopausal breast cancer risk: results from the Breakthrough Generations Study

Combination therapy with aromatase inhibitors: the next era of breast cancer treatment?

Polymorphisms Associated With Circulating Sex Hormone Levels in Postmenopausal Women

HER2 testing in the UK: further update to recommendations

Enhanced expression of the PDGFR/Abl signaling pathway in aromatase inhibitor-resistant breast cancer

Interim analysis of the incidence of breast cancer in the Royal Marsden Hospital tamoxifen randomised chemoprevention trial

Aktive Filter

Suchergebnisse filtern